Mannatech (NASDAQ:MTEX) Share Price Passes Below 200 Day Moving Average – Here’s What Happened

Mannatech, Incorporated (NASDAQ:MTEX) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $6.08 and traded as low as $4.37. Mannatech shares last traded at $4.58, with a volume of 11,133 shares.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Mannatech Price Performance

The company’s 50-day moving average price is $5.09 and its two-hundred day moving average price is $6.08. The company has a market capitalization of $8.84 million, a price-to-earnings ratio of -0.68 and a beta of 0.72.

Mannatech (NASDAQ:MTEX) last released its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. The business had revenue of $24.92 million for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%.

Insider Activity

In other news, Director Kevin Andrew Robbins acquired 7,100 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $4.17 per share, with a total value of $29,607.00. Following the acquisition, the director directly owned 33,333 shares of the company’s stock, valued at $138,998.61. The trade was a 27.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders purchased a total of 14,903 shares of company stock worth $62,155 over the last 90 days. 47.50% of the stock is owned by insiders.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.